Patients Stopping Slimming Injections Regain Weight Four Times Faster Compared to People Using Diet and Exercise

New research reveals that people who stop using new slimming jabs like semaglutide or tirzepatide may regain lost weight far faster than those who end conventional lifestyle plans.

Research printed in a prominent health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing these drugs should be informed of the risk of rapid rebound weight gain when the treatment concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain means a return to original mass in about a year and a half.

Analyzing Approaches

The analysis, which reviewed dozens of trials involving thousands of participants, compared the results of these new drugs with other pills.

Scientists emphasize that individuals who shed pounds through lifestyle changes alone usually experience a slower creep back—around 0.1 kg a month—post-intervention.

The Reason for the Quick Regain

Doctors believe the way of the drugs accounts for the heightened regain.

The injections imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Artificially providing the hormone levels far above than normal might result in the system to produce less of its endogenous GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making binge eating a significant risk."

A Chronic Disease?

The NHS suggest the jabs for people with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts say that, due to the high risk of weight regain, the therapy might need to be long-term.

This opinion is reinforced by drug manufacturers, who say that the findings "emphasize the long-term character of obesity," similar to managing conditions like high blood pressure.

Patient Accounts

Individuals who have come off the jabs explain a intense return of hunger.

"It was like a trigger that goes on and you're instantly ravenous," described one woman.

This difficulty is exacerbated if individuals have not adopted permanent dietary or behavioural modifications during therapy.

Significant Use

Recent estimates show that millions of people in the UK have tried these injections in the last 12 months, with desire continuing to grow.

• Use is more common among women than men.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion access the drugs through private prescriptions rather than public health services.

Finally, clinicians emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic solution and maintained weight loss hinges on integrated behavioural changes.